17 results
424B3
IKT
Inhibikase Therapeutics Inc
4 Apr 23
Prospectus supplement
4:57pm
for costs and expenses we may incur due to injuries to our employees resulting from the use of hazardous materials, this insurance may not provide
POS AM
IKT
Inhibikase Therapeutics Inc
31 Mar 23
Prospectus update (post-effective amendment)
4:11pm
insurance to cover us for costs and expenses we may incur due to injuries to our employees resulting from the use of hazardous materials, this insurance may
424B4
7zvh0179pyhz7qei3gzb
17 Jun 21
Prospectus supplement with pricing info
4:31pm
DRS
jaf012v6 2j4
2 Jun 21
Draft registration statement
12:00am
10-K
xsq7qz2a6h4skjc0o28
31 Mar 21
Annual report
2:14pm
424B4
3e2qe bnz7hp
28 Dec 20
Prospectus supplement with pricing info
6:04am
S-1
dog58
23 Jul 20
IPO registration
12:28pm
DRS/A
0tliuiw1
16 Oct 18
Draft registration statement (amended)
12:00am
- Prev
- 1
- Next